Multidisciplinary rehabilitation after primary brain tumour treatment.
Identifieur interne : 001C33 ( Main/Exploration ); précédent : 001C32; suivant : 001C34Multidisciplinary rehabilitation after primary brain tumour treatment.
Auteurs : Fary Khan ; Bhasker Amatya ; Louisa Ng ; Kate Drummond ; Mary GaleaSource :
- The Cochrane database of systematic reviews [ 1469-493X ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- méthodes : Association thérapeutique.
- rééducation et réadaptation : Tumeurs du cerveau.
- thérapie : Tumeurs du cerveau.
- Adulte, Canal anal, Essais cliniques contrôlés comme sujet, Humains, Locomotion, Participation sociale, Qualité de vie.
English descriptors
- KwdEn :
- MESH :
- methods : Combined Modality Therapy.
- rehabilitation : Brain Neoplasms.
- therapy : Brain Neoplasms.
- Adult, Anal Canal, Controlled Clinical Trials as Topic, Humans, Locomotion, Quality of Life, Social Participation.
Abstract
BACKGROUND
Brain tumours can cause significant disability, which may be amenable to multidisciplinary rehabilitation. However, the evidence base for this is unclear. This review is an update of a previously published review in the Cochrane Database of Systematic Reviews [2013, Issue 1, Art. No. CD009509] on 'Multidisciplinary rehabilitation after primary brain tumour treatment'.
OBJECTIVES
To assess the effectiveness of multidisciplinary rehabilitation in people after primary brain tumour treatment, especially the types of approaches that are effective (settings, intensity).
SEARCH METHODS
For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library up to Issue 12 of 12, 2014), MEDLINE (1950 to January week 2, 2015), EMBASE (1980 to January week 2, 2015), PEDro (1985 to January week 2 2015), and LILACS (1982 to January week 2, 2015). We checked the bibliographies of papers we identified and contacted the authors and known experts in the field to seek published and unpublished trials.
SELECTION CRITERIA
Controlled clinical trials (randomised and non-randomised clinical trials) that compared multidisciplinary rehabilitation in primary brain tumour with either routinely available local services or lower levels of intervention, or studies that compared multidisciplinary rehabilitation in different settings or at different levels of intensity.
DATA COLLECTION AND ANALYSIS
Three review authors independently assessed study quality, extracted data, and performed a 'best evidence ' synthesis based on methodological quality.
MAIN RESULTS
We did not identify any studies for inclusion in the previous version of this review. For this update, the literature search identified one low-quality controlled clinical trial involving 106 participants. The findings from this study suggest 'low-level' evidence to support high-intensity ambulatory (outpatient) multidisciplinary rehabilitation in reducing short- and long-term motor disability (continence, mobility and locomotion, cognition), when compared with standard outpatient care. We found improvement in some domains of disability (continence, communication) and psychosocial gains were maintained at six months follow-up. We found no evidence for improvement in overall participation (quality of life and societal relationship). No adverse events were reported as a result of multidisciplinary rehabilitation. We found no evidence for improvement in quality of life or cost-effectiveness of rehabilitation. It was also not possible to suggest best 'dose' of therapy.
AUTHORS' CONCLUSIONS
Since the last version of this review, one new study has been identified for inclusion. The best evidence to date comes from this CCT, which provides low quality evidence that higher intensity ambulatory (outpatient) multidisciplinary rehabilitation reduces short- and long-term disability in people with brain tumour compared with standard outpatient care. Our conclusions are tentative at best, given gaps in current research in this area. Although the strength of evidence has increased with the identification of a new controlled clinical trial in this updated review, further research is needed into appropriate and robust study designs; outcome measurement; caregiver needs; evaluation of optimal settings; type, intensity, duration of therapy; and cost-effectiveness of multidisciplinary rehabilitation in the brain tumour population.
DOI: 10.1002/14651858.CD009509.pub3
PubMed: 26298178
PubMed Central: PMC6481476
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multidisciplinary rehabilitation after primary brain tumour treatment.</title><author><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name><affiliation><nlm:affiliation>Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Poplar Road, Parkville, Melbourne, Victoria, Australia, 3052.</nlm:affiliation><wicri:noCountry code="subField">3052</wicri:noCountry></affiliation></author><author><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name></author><author><name sortKey="Ng, Louisa" sort="Ng, Louisa" uniqKey="Ng L" first="Louisa" last="Ng">Louisa Ng</name></author><author><name sortKey="Drummond, Kate" sort="Drummond, Kate" uniqKey="Drummond K" first="Kate" last="Drummond">Kate Drummond</name></author><author><name sortKey="Galea, Mary" sort="Galea, Mary" uniqKey="Galea M" first="Mary" last="Galea">Mary Galea</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26298178</idno><idno type="pmid">26298178</idno><idno type="doi">10.1002/14651858.CD009509.pub3</idno><idno type="pmc">PMC6481476</idno><idno type="wicri:Area/Main/Corpus">001B57</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001B57</idno><idno type="wicri:Area/Main/Curation">001B57</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001B57</idno><idno type="wicri:Area/Main/Exploration">001B57</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Multidisciplinary rehabilitation after primary brain tumour treatment.</title><author><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name><affiliation><nlm:affiliation>Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Poplar Road, Parkville, Melbourne, Victoria, Australia, 3052.</nlm:affiliation><wicri:noCountry code="subField">3052</wicri:noCountry></affiliation></author><author><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name></author><author><name sortKey="Ng, Louisa" sort="Ng, Louisa" uniqKey="Ng L" first="Louisa" last="Ng">Louisa Ng</name></author><author><name sortKey="Drummond, Kate" sort="Drummond, Kate" uniqKey="Drummond K" first="Kate" last="Drummond">Kate Drummond</name></author><author><name sortKey="Galea, Mary" sort="Galea, Mary" uniqKey="Galea M" first="Mary" last="Galea">Mary Galea</name></author></analytic><series><title level="j">The Cochrane database of systematic reviews</title><idno type="eISSN">1469-493X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Anal Canal (MeSH)</term><term>Brain Neoplasms (rehabilitation)</term><term>Brain Neoplasms (therapy)</term><term>Combined Modality Therapy (methods)</term><term>Controlled Clinical Trials as Topic (MeSH)</term><term>Humans (MeSH)</term><term>Locomotion (MeSH)</term><term>Quality of Life (MeSH)</term><term>Social Participation (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Association thérapeutique (méthodes)</term><term>Canal anal (MeSH)</term><term>Essais cliniques contrôlés comme sujet (MeSH)</term><term>Humains (MeSH)</term><term>Locomotion (MeSH)</term><term>Participation sociale (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Tumeurs du cerveau (rééducation et réadaptation)</term><term>Tumeurs du cerveau (thérapie)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Combined Modality Therapy</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Association thérapeutique</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Brain Neoplasms</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Tumeurs du cerveau</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Brain Neoplasms</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs du cerveau</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Anal Canal</term><term>Controlled Clinical Trials as Topic</term><term>Humans</term><term>Locomotion</term><term>Quality of Life</term><term>Social Participation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Canal anal</term><term>Essais cliniques contrôlés comme sujet</term><term>Humains</term><term>Locomotion</term><term>Participation sociale</term><term>Qualité de vie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Brain tumours can cause significant disability, which may be amenable to multidisciplinary rehabilitation. However, the evidence base for this is unclear. This review is an update of a previously published review in the Cochrane Database of Systematic Reviews [2013, Issue 1, Art. No. CD009509] on 'Multidisciplinary rehabilitation after primary brain tumour treatment'.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p>To assess the effectiveness of multidisciplinary rehabilitation in people after primary brain tumour treatment, especially the types of approaches that are effective (settings, intensity).</p></div><div type="abstract" xml:lang="en"><p><b>SEARCH METHODS</b></p><p>For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library up to Issue 12 of 12, 2014), MEDLINE (1950 to January week 2, 2015), EMBASE (1980 to January week 2, 2015), PEDro (1985 to January week 2 2015), and LILACS (1982 to January week 2, 2015). We checked the bibliographies of papers we identified and contacted the authors and known experts in the field to seek published and unpublished trials.</p></div><div type="abstract" xml:lang="en"><p><b>SELECTION CRITERIA</b></p><p>Controlled clinical trials (randomised and non-randomised clinical trials) that compared multidisciplinary rehabilitation in primary brain tumour with either routinely available local services or lower levels of intervention, or studies that compared multidisciplinary rehabilitation in different settings or at different levels of intensity.</p></div><div type="abstract" xml:lang="en"><p><b>DATA COLLECTION AND ANALYSIS</b></p><p>Three review authors independently assessed study quality, extracted data, and performed a 'best evidence ' synthesis based on methodological quality.</p></div><div type="abstract" xml:lang="en"><p><b>MAIN RESULTS</b></p><p>We did not identify any studies for inclusion in the previous version of this review. For this update, the literature search identified one low-quality controlled clinical trial involving 106 participants. The findings from this study suggest 'low-level' evidence to support high-intensity ambulatory (outpatient) multidisciplinary rehabilitation in reducing short- and long-term motor disability (continence, mobility and locomotion, cognition), when compared with standard outpatient care. We found improvement in some domains of disability (continence, communication) and psychosocial gains were maintained at six months follow-up. We found no evidence for improvement in overall participation (quality of life and societal relationship). No adverse events were reported as a result of multidisciplinary rehabilitation. We found no evidence for improvement in quality of life or cost-effectiveness of rehabilitation. It was also not possible to suggest best 'dose' of therapy.</p></div><div type="abstract" xml:lang="en"><p><b>AUTHORS' CONCLUSIONS</b></p><p>Since the last version of this review, one new study has been identified for inclusion. The best evidence to date comes from this CCT, which provides low quality evidence that higher intensity ambulatory (outpatient) multidisciplinary rehabilitation reduces short- and long-term disability in people with brain tumour compared with standard outpatient care. Our conclusions are tentative at best, given gaps in current research in this area. Although the strength of evidence has increased with the identification of a new controlled clinical trial in this updated review, further research is needed into appropriate and robust study designs; outcome measurement; caregiver needs; evaluation of optimal settings; type, intensity, duration of therapy; and cost-effectiveness of multidisciplinary rehabilitation in the brain tumour population.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26298178</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>8</Issue><PubDate><Year>2015</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Multidisciplinary rehabilitation after primary brain tumour treatment.</ArticleTitle><Pagination><MedlinePgn>CD009509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD009509.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brain tumours can cause significant disability, which may be amenable to multidisciplinary rehabilitation. However, the evidence base for this is unclear. This review is an update of a previously published review in the Cochrane Database of Systematic Reviews [2013, Issue 1, Art. No. CD009509] on 'Multidisciplinary rehabilitation after primary brain tumour treatment'.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the effectiveness of multidisciplinary rehabilitation in people after primary brain tumour treatment, especially the types of approaches that are effective (settings, intensity).</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library up to Issue 12 of 12, 2014), MEDLINE (1950 to January week 2, 2015), EMBASE (1980 to January week 2, 2015), PEDro (1985 to January week 2 2015), and LILACS (1982 to January week 2, 2015). We checked the bibliographies of papers we identified and contacted the authors and known experts in the field to seek published and unpublished trials.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Controlled clinical trials (randomised and non-randomised clinical trials) that compared multidisciplinary rehabilitation in primary brain tumour with either routinely available local services or lower levels of intervention, or studies that compared multidisciplinary rehabilitation in different settings or at different levels of intensity.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Three review authors independently assessed study quality, extracted data, and performed a 'best evidence ' synthesis based on methodological quality.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We did not identify any studies for inclusion in the previous version of this review. For this update, the literature search identified one low-quality controlled clinical trial involving 106 participants. The findings from this study suggest 'low-level' evidence to support high-intensity ambulatory (outpatient) multidisciplinary rehabilitation in reducing short- and long-term motor disability (continence, mobility and locomotion, cognition), when compared with standard outpatient care. We found improvement in some domains of disability (continence, communication) and psychosocial gains were maintained at six months follow-up. We found no evidence for improvement in overall participation (quality of life and societal relationship). No adverse events were reported as a result of multidisciplinary rehabilitation. We found no evidence for improvement in quality of life or cost-effectiveness of rehabilitation. It was also not possible to suggest best 'dose' of therapy.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Since the last version of this review, one new study has been identified for inclusion. The best evidence to date comes from this CCT, which provides low quality evidence that higher intensity ambulatory (outpatient) multidisciplinary rehabilitation reduces short- and long-term disability in people with brain tumour compared with standard outpatient care. Our conclusions are tentative at best, given gaps in current research in this area. Although the strength of evidence has increased with the identification of a new controlled clinical trial in this updated review, further research is needed into appropriate and robust study designs; outcome measurement; caregiver needs; evaluation of optimal settings; type, intensity, duration of therapy; and cost-effectiveness of multidisciplinary rehabilitation in the brain tumour population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fary</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Poplar Road, Parkville, Melbourne, Victoria, Australia, 3052.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amatya</LastName><ForeName>Bhasker</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Louisa</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Drummond</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Galea</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2013;(1):CD009509</RefSource><PMID Version="1">23440839</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018849" MajorTopicYN="N">Controlled Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058992" MajorTopicYN="N">Social Participation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26298178</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD009509.pub3</ArticleId><ArticleId IdType="pmc">PMC6481476</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Br J Cancer. 1999 Aug;80(11):1770-80</Citation><ArticleIdList><ArticleId IdType="pubmed">10468295</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Phys Med Rehabil. 2000 Jul-Aug;79(4):327-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10892618</ArticleId></ArticleIdList></Reference><Reference><Citation>Assist Technol. 1999;11(2):105-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11010061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Control. 2000 Nov-Dec;7(6):523-38</Citation><ArticleIdList><ArticleId IdType="pubmed">11088061</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2001 Apr;82(4):457-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11295004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2001 Aug 15;92(4 Suppl):1029-38</Citation><ArticleIdList><ArticleId IdType="pubmed">11519030</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Inj. 2001 Oct;15(10):843-56</Citation><ArticleIdList><ArticleId IdType="pubmed">11595081</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2001 Nov;82(11):1540-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11689973</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Med Rehabil Clin N Am. 2001 Feb;12(1):153-68</Citation><ArticleIdList><ArticleId IdType="pubmed">11853034</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2002 Sep;83(9):1320-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12235618</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2002;(4):CD003913</Citation><ArticleIdList><ArticleId IdType="pubmed">12519620</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Otolaryngol. 2002 Dec;122(8):841-50</Citation><ArticleIdList><ArticleId IdType="pubmed">12542203</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Jun 15;49(3):349-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12794790</ArticleId></ArticleIdList></Reference><Reference><Citation>Spine (Phila Pa 1976). 2003 Jun 15;28(12):1290-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12811274</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Radiat Oncol. 2003 Jul;13(3):248-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12903014</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 1992 Feb;1(1):19-29</Citation><ArticleIdList><ArticleId IdType="pubmed">1301111</ArticleId></ArticleIdList></Reference><Reference><Citation>Md State Med J. 1965 Feb;14:61-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2004 May 22;363(9422):1665-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15158627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2004 Jul;36(4):159-64</Citation><ArticleIdList><ArticleId IdType="pubmed">15370731</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Sci. 2005 May;26 Suppl 1:S51-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15883697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004170</Citation><ArticleIdList><ArticleId IdType="pubmed">16034923</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2006 Feb 1;24(4):635-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16446335</ArticleId></ArticleIdList></Reference><Reference><Citation>Res Nurs Health. 2006 Apr;29(2):105-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16532486</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Phys Med Rehabil. 2006 Jul;85(7):568-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16788387</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2006 Jun 29;4:36</Citation><ArticleIdList><ArticleId IdType="pubmed">16808842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005001</Citation><ArticleIdList><ArticleId IdType="pubmed">17054230</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2007 May;15(5):515-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17120068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2007 Apr 18;(2):CD006036</Citation><ArticleIdList><ArticleId IdType="pubmed">17443610</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2007 Aug;114(2):97-109</Citation><ArticleIdList><ArticleId IdType="pubmed">17618441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000197</Citation><ArticleIdList><ArticleId IdType="pubmed">17943737</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Med Rehabil Clin N Am. 2007 Nov;18(4):899-924, viii</Citation><ArticleIdList><ArticleId IdType="pubmed">17967368</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Clin Cancer Res. 2007 Sep;26(3):297-300</Citation><ArticleIdList><ArticleId IdType="pubmed">17987786</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2008 Jun;255(6):820-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18500499</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Fam Physician. 2008 May 15;77(10):1423-30</Citation><ArticleIdList><ArticleId IdType="pubmed">18533376</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rehabil. 2008 Aug;22(8):698-713</Citation><ArticleIdList><ArticleId IdType="pubmed">18678570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1991 Sep 15;68(6):1406-13</Citation><ArticleIdList><ArticleId IdType="pubmed">1873793</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Phys Rehabil Med. 2008 Sep;44(3):303-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18762740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurosci. 2009 Jan;16(1):74-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19022673</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2009;31(13):1038-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19116809</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2009 Jul;15(7):869-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19465445</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Aug 1;27(22):3712-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19470928</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49</Citation><ArticleIdList><ArticleId IdType="pubmed">19474385</ArticleId></ArticleIdList></Reference><Reference><Citation>Head Neck. 2010 Feb;32(2):210-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19572286</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2009;31(13):1066-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19802924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007425</Citation><ArticleIdList><ArticleId IdType="pubmed">19821416</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Phys Med Rehabil. 2010 Mar;89(3):205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20068429</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Palliat Nurs. 2010 Jan;16(1):24-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20090660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005211</Citation><ArticleIdList><ArticleId IdType="pubmed">20556760</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2010 Jun 15;116(12):3034-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20564409</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2010 Oct 06;(10):CD008505</Citation><ArticleIdList><ArticleId IdType="pubmed">20927774</ArticleId></ArticleIdList></Reference><Reference><Citation>J Otolaryngol Head Neck Surg. 2010 Dec;39(6):674-87</Citation><ArticleIdList><ArticleId IdType="pubmed">21144364</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2012 Apr;20(4):805-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21533813</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Phys Med Rehabil. 2011 May;90(5 Suppl 1):S50-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21765264</ArticleId></ArticleIdList></Reference><Reference><Citation>PM R. 2011 Aug;3(8):746-57</Citation><ArticleIdList><ArticleId IdType="pubmed">21871419</ArticleId></ArticleIdList></Reference><Reference><Citation>Head Neck. 2012 Jul;34(7):956-66</Citation><ArticleIdList><ArticleId IdType="pubmed">21953733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurooncol. 2012 May;107(3):537-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22124725</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2012 Aug;93(8 Suppl):S127-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22840879</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2012 Sep;44(9):788-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22858869</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2012 Dec 12;12:CD009553</Citation><ArticleIdList><ArticleId IdType="pubmed">23235677</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurooncol. 2013 Feb;111(3):355-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23292152</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009509</Citation><ArticleIdList><ArticleId IdType="pubmed">23440839</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2013 May;45(5):434-45</Citation><ArticleIdList><ArticleId IdType="pubmed">23584801</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurooncol. 2013 Aug;114(1):93-100</Citation><ArticleIdList><ArticleId IdType="pubmed">23677749</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2013 Jul 11;3(7):null</Citation><ArticleIdList><ArticleId IdType="pubmed">23847270</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Aging. 2013 Sep;32(3):278-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23915910</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2014 May;22(5):1261-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24317851</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2014 Sep;46(8):754-60</Citation><ArticleIdList><ArticleId IdType="pubmed">24940656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurs Res. 1989 Nov-Dec;38(6):348-51</Citation><ArticleIdList><ArticleId IdType="pubmed">2587289</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J (Clin Res Ed). 1987 Sep 12;295(6599):654-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3117277</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin North Am. 1969 May;53(3):607-24</Citation><ArticleIdList><ArticleId IdType="pubmed">4305950</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1994 Jan;18 Suppl 1:S79-83</Citation><ArticleIdList><ArticleId IdType="pubmed">8148458</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1996 Jan;77(1):54-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8554474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1997 Jul 15;80(2):250-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9217038</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1998 Jan 3;316(7124):61-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9451274</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1998 Mar;79(3):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9523772</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1998 Nov;16(11):3563-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9817276</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1998 Nov;79(11):1386-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9821898</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1998 Dec;79(12):1530-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9862294</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name><name sortKey="Drummond, Kate" sort="Drummond, Kate" uniqKey="Drummond K" first="Kate" last="Drummond">Kate Drummond</name><name sortKey="Galea, Mary" sort="Galea, Mary" uniqKey="Galea M" first="Mary" last="Galea">Mary Galea</name><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name><name sortKey="Ng, Louisa" sort="Ng, Louisa" uniqKey="Ng L" first="Louisa" last="Ng">Louisa Ng</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26298178
|texte= Multidisciplinary rehabilitation after primary brain tumour treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26298178" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |